Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Informs Canadian Wholesalers Of Coreg, Paxil, Relafen Shortages

Executive Summary

GlaxoSmithKline is informing Canadian pharmacists and wholesalers that it will not be able to fill orders of Coreg, Paxil and Relafen until the end of the year
Advertisement

Related Content

GSK’s Six Launches, Six Filings Slated For ’06: Sign Of R&D Strategy Payoff?
GSK’s Six Launches, Six Filings Slated For ’06: Sign Of R&D Strategy Payoff?
GSK Signs GMP Consent Decree For Cidra Plant But Avoids Disgorgement Fee
Paxil CR, Avandamet Seizure Threatens $1 Bil. In Annual Revenue For GSK
Paxil CR, Avandamet Seizure Threatens $1 Bil. In Annual Revenue For GSK

Topics

Advertisement
UsernamePublicRestriction

Register

PS046329

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel